Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy
- Conditions
- Registration Number
- NCT06425575
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
This goal of this study is to determine whether a novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life (QoL) in women stricken with chronic pelvic pain (CPP). The main questions it aims to answer are:
* Weather pain in the genitalia is reduced with treatment
...
- Detailed Description
This is an observational study and is driven by the hypothesis that novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life in women stricken with chronic pelvic pain (CPP). This clinical trial is performed in a hospital-based practice at Thomas Jefferson University in which all patients over the age of 18 ...
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 50
All patients 18 years of age or older who present with chronic pelvic pain -
- Under 18 years of age
- Malignancy defined as terminal -
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Pain and overall quality of life Between 6 and 12 months after treatment Pain in structures of the genitalia, rectum and pain during sexual activity
- Secondary Outcome Measures
Name Time Method Adverse events Between 6 and 12 months after treatment Zero pain relief
Bladder pain and urination frequency Between 6 and 12 months after treatment Symptoms relating to interstitial cystitis
Trial Locations
- Locations (1)
Thomas Jefferwson University Hospital
🇺🇸Philadelphia, Pennsylvania, United States